FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sabine Classen

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Procedures

Co-author Network

Publications

TOP 3
Marc Beyer; Sabine Classen; Elmar Endl; Thomas Giese; Percy A Knolle; Andreas Limmer; Beatrix Schumak; Martin R Weihrauch; Bettina Andres; Joachim L Schultze
In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration.
Thomas Zander; Sascha Ansén; Marc Beyer; Sabine Classen; Svenja Debey-Pascher; Karl-Stefan Delank; Walburga Engel-Riedel; Birgit Gathof; Moritz Hahn; Andrea Hofmann; Daniela Maisel; Cornelia Mauch; Joachim L Schultze; Andrea Staratschek-Jox; Erich Stoelben; Roman K Thomas; H-Erich Wichmann; Jürgen Wolf
Blood-based gene expression signatures in non-small cell lung cancer.
Marc Beyer; Sabine Classen; Svenja Debey-Pascher; Elmar Endl; Percy A Knolle; Matthias Kochanek; Martin R Weihrauch; Joachim L Schultze
Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sabine Classen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Marc Beyer; Sabine Classen; Elmar Endl; Thomas Giese; Percy A Knolle; Andreas Limmer; Beatrix Schumak; Martin R Weihrauch; Bettina Andres; Joachim L Schultze
In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administration.
PloS one 2012;7(1):e30422.
2011: Thomas Zander; Sascha Ansén; Marc Beyer; Sabine Classen; Svenja Debey-Pascher; Karl-Stefan Delank; Walburga Engel-Riedel; Birgit Gathof; Moritz Hahn; Andrea Hofmann; Daniela Maisel; Cornelia Mauch; Joachim L Schultze; Andrea Staratschek-Jox; Erich Stoelben; Roman K Thomas; H-Erich Wichmann; Jürgen Wolf
Blood-based gene expression signatures in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(10):3360-7.
2011: Marc Beyer; Sabine Classen; Svenja Debey-Pascher; Elmar Endl; Percy A Knolle; Matthias Kochanek; Martin R Weihrauch; Joachim L Schultze
Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.
Clinical & developmental immunology 2011;2011():734036.
2010: Manoj K Gupta; Damir J Illich; Andrea Gaarz; Matthias Matzkies; Filomain Nguemo; Kurt Pfannkuche; Huamin Liang; Sabine Classen; Michael Reppel; Joachim L Schultze; Jürgen Hescheler; Tomo Sarić
Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar.
BMC developmental biology 2010;10():98.
2007: Jens M Chemnitz; Daniela Eggle; Julia Driesen; Sabine Classen; James L Riley; Svenja Debey-Pascher; Marc Beyer; Alexey Popov; Thomas Zander; Joachim L Schultze
RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma.
Blood 2007;110(9):3226-33.
2007: Sabine Classen; Thomas Zander; Daniela Eggle; Jens M Chemnitz; Benedikt Brors; Ingrid Büchmann; Alexey Popov; Marc Beyer; Roland Eils; Svenja Debey; Joachim L Schultze
Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(11):6931-40.
2007: Ari Waisman; Manfred Kraus; Jane Seagal; Snigdha Ghosh; Doron Melamed; Jian Song; Yoshiteru Sasaki; Sabine Classen; Claudia Lutz; Frank Brombacher; Lars Nitschke; Klaus Rajewsky
IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta.
The Journal of experimental medicine 2007;204(4):747-58.
2006: Michael S von Bergwelt-Baildon; Alexey Popov; Tomo Saric; Jens M Chemnitz; Sabine Classen; Marc S Stoffel; Francesca Fiore; Udo Roth; Marc Beyer; Svenja Debey; Claudia Wickenhauser; Franz-Georg Hanisch; Joachim L Schultze
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition.
Blood 2006;108(1):228-37.
2006: Marc Beyer; Matthias Kochanek; Thomas Giese; Elmar Endl; Martin R Weihrauch; Percy A Knolle; Sabine Classen; Joachim L Schultze
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.
Blood 2006;107(10):3940-9.
2006: Jens M Chemnitz; Julia Driesen; Sabine Classen; James L Riley; Svenja Debey; Marc Beyer; Alexey Popov; Thomas Zander; Joachim L Schultze
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma.
Cancer research 2006;66(2):1114-22.